Metoprolol Tartrate

Product manufactured by Direct_rx

Application Nr Approved Date Route Status External Links
ANDA074644 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications & Usage Section Hypertension Metoprolol Tartrate Tablets Are Indicated For The Treatment Of Hypertension. They May Be Used Alone Or In Combination With Other Antihypertensive Agents. Angina Pectoris Metoprolol Tartrate Tablets Are Indicated In The Long-Term Treatment Of Angina Pectoris. Myocardial Infarction Metoprolol Tartrate Injection And Tablets Are Indicated In The Treatment Of Hemodynamically Stable Patients With Definite Or Suspected Acute Myocardial Infarction To Reduce Cardiovascular Mortality. Treatment With Intravenous Metoprolol Tartrate Can Be Initiated As Soon As The Patient’s Clinical Condition Allows (See Dosage And Administration , Contraindications , And Warnings ). Alternatively, Treatment Can Begin Within 3 To 10 Days Of The Acute Event (See Dosage And Administration ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Metoprolol Tartrate METOPROLOL TARTRATE ZINC1530717

Comments